NATURE . COM {}

Matching Content Categories {📚}

• Science
• Education
• News & Politics

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}

Display Ads {🎯}

The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)

google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)

conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}

Display Ads {🎯}

$63,100 per month
Our estimates place Nature.com's monthly online earnings from display ads at $42,042 to $115,616.

Keywords {🔍}

antibiotics, nature, drug, antibiotic, companies, paratek, million, article, company, research, year, people, market, resistance, loh, university, google, scholar, content, privacy, cookies, news, drugs, pharmaceuticals, small, years, infections, make, data, sign, resistant, omadacycline, united, states, disease, chief, business, development, approval, open, pubmed, analysis, covid, early, treat, executive, infection, team, pharmaceutical, cost,

Topics {✒️}

scientific research personnel nature portfolio paratek formed partnerships joao silva/nyt/redux/eyevine south africa battles privacy policy advertising open forum infect permissions latest social media nature briefing research positions focusing biomedical advanced research nature rev author antibiotic-resistance research language problem nature research positions simon dawson/bloomberg/getty open antibiotics turn toxic amassed abundant data antibiotic portfolio community-acquired bacterial pneumonia research laboratory access life-saving medicines personal data antibiotic-development consultant data protection long-time drug developer hiring faculty members privacy journals search log chief development jena university hospital explore content selected content european economic area develop bacterial pneumonias purchase price covered structure incorporates tweaks nasdaq stock exchange careful restaffing programme led transplant programmes enduring economic puzzle development authority gut microbiome ravaged medicine seeks phds

Questions {❓}

• Should I open the doors on Monday?
• So why is the company’s long-term survival in question?
• “When you come from a big company to a small company, your focus becomes: ‘How do I make sure this company survives?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The antibiotic paradox: why companies can’t afford to create life-saving drugs
         description:Paratek Pharmaceuticals successfully brought a new antibiotic to the market. So why is the company’s long-term survival in question? Paratek Pharmaceuticals successfully brought a new antibiotic to the market. So why is the company’s long-term survival in question?
         datePublished:2020-08-19T00:00:00Z
         dateModified:2020-08-19T00:00:00Z
         pageStart:338
         pageEnd:341
         sameAs:https://doi.org/10.1038/d41586-020-02418-x
         keywords:
            Antibiotics
            Business
            Diseases
            Infection
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
            https://images.nature.com/lw1200/magazine-assets/d41586-020-02418-x/d41586-020-02418-x_18278468.jpg
            https://images.nature.com/lw1200/magazine-assets/d41586-020-02418-x/d41586-020-02418-x_18287748.png
            https://images.nature.com/lw1200/magazine-assets/d41586-020-02418-x/d41586-020-02418-x_18278474.jpg
            https://images.nature.com/lw1200/magazine-assets/d41586-020-02418-x/d41586-020-02418-x_18287750.png
         isPartOf:
            name:Nature
            volumeNumber:584
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Maryn McKenna
               type:Person
         isAccessibleForFree:1
         type:NewsArticle
      context:https://schema.org
NewsArticle:
      headline:The antibiotic paradox: why companies can’t afford to create life-saving drugs
      description:Paratek Pharmaceuticals successfully brought a new antibiotic to the market. So why is the company’s long-term survival in question? Paratek Pharmaceuticals successfully brought a new antibiotic to the market. So why is the company’s long-term survival in question?
      datePublished:2020-08-19T00:00:00Z
      dateModified:2020-08-19T00:00:00Z
      pageStart:338
      pageEnd:341
      sameAs:https://doi.org/10.1038/d41586-020-02418-x
      keywords:
         Antibiotics
         Business
         Diseases
         Infection
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
         https://images.nature.com/lw1200/magazine-assets/d41586-020-02418-x/d41586-020-02418-x_18278468.jpg
         https://images.nature.com/lw1200/magazine-assets/d41586-020-02418-x/d41586-020-02418-x_18287748.png
         https://images.nature.com/lw1200/magazine-assets/d41586-020-02418-x/d41586-020-02418-x_18278474.jpg
         https://images.nature.com/lw1200/magazine-assets/d41586-020-02418-x/d41586-020-02418-x_18287750.png
      isPartOf:
         name:Nature
         volumeNumber:584
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Maryn McKenna
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Nature
      volumeNumber:584
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Maryn McKenna

Social Networks {👍}(4)

• https://www.facebook.com/Nature
• https://twitter.com/nature
• https://twitter.com/intent/tweet?text=The+antibiotic+paradox%3A+why+companies+can%E2%80%99t+afford+to+create+life-saving+drugs&url=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41586-020-02418-x
• http://www.facebook.com/sharer.php?u=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41586-020-02418-x

External Links {🔗}(27)

• What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Maryn+McKenna each month?
• How much income does https://scholar.google.co.uk/scholar?as_q=&btnG=Search+Scholar&as_sauthors=%22Maryn%2BMcKenna%22 have?
• Income figures for https://doi.org/10.1016%2Fj.jhealeco.2016.01.012
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26928437 produce monthly?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=&journal=J.%20Health%20Econ.&doi=10.1016%2Fj.jhealeco.2016.01.012&volume=47&pages=20-33&publication_year=2016&author=DiMasi%2CJ.%20A.&author=Grabowski%2CH.%20G.&author=Hansen%2CR.%20W.
• What are the earnings of https://doi.org/10.1128%2FAAC.02057-19?
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=&journal=Antimicrob.%20Agents%20Chemother.&doi=10.1128%2FAAC.02057-19&volume=64&publication_year=2020&author=Shlaes%2CD.%20M.?
• What's the financial gain of https://doi.org/10.1128%2FAAC.01733-19?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=&journal=Antimicrob.%20Agents%20Chemother.&doi=10.1128%2FAAC.01733-19&volume=63&publication_year=2019&author=Clancy%2CC.%20J.&author=Nguyen%2CM.%20H.?
• How much does https://doi.org/10.1093%2Fofid%2Fofz344 bring in each month?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31660388 generate?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=&journal=Open%20Forum%20Infect.%20Dis.&doi=10.1093%2Fofid%2Fofz344&volume=6&publication_year=2019&author=Clancy%2CC.%20J.&author=Potoski%2CB.%20A.&author=Buehrle%2CD.&author=Nguyen%2CM.%20H. generate?
• How much money does https://doi.org/10.1016%2FS0140-6736%2820%2930211-7 make?
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32007143 is on a monthly basis
• What's http://scholar.google.com/scholar_lookup?&title=&journal=Lancet&doi=10.1016%2FS0140-6736%2820%2930211-7&volume=395&pages=507-513&publication_year=2020&author=Chen%2CN.'s gross income?
• How much income is https://doi.org/10.1016%2FS0140-6736%2820%2930566-3 earning monthly?
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32171076?
• How much profit is http://scholar.google.com/scholar_lookup?&title=&journal=Lancet&doi=10.1016%2FS0140-6736%2820%2930566-3&volume=395&pages=1054-1062&publication_year=2020&author=Zhou%2CF. making per month?
• How much does https://doi.org/10.1038%2Fs41579-020-0395-y earn?
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32488173 is on a monthly basis
• http://scholar.google.com/scholar_lookup?&title=&journal=Nature%20Rev.%20Microbiol.&doi=10.1038%2Fs41579-020-0395-y&volume=18&pages=409-410&publication_year=2020&author=Rawson%2CT.%20A.&author=Ming%2CD.&author=Ahmad%2CR.&author=Moore%2CL.%20S.%20P.&author=Holmes%2CA.%20H.'s total income per month
• Get to know https://citation-needed.springer.com/v2/references/10.1038/d41586-020-02418-x?format=refman&flavour=references's earnings
• How much cash flow does https://s100.copyright.com/AppDispatchServlet?title=The%20antibiotic%20paradox%3A%20why%20companies%20can%E2%80%99t%20afford%20to%20create%20life-saving%20drugs&author=Maryn%20McKenna&contentID=10.1038%2Fd41586-020-02418-x©right=Springer%20Nature%20Limited&publication=0028-0836&publicationDate=2020-08-19&publisherName=SpringerNature&orderBeanReset=true have monthly?
• What's the monthly income of https://www.protocols.io/?
• How much profit does https://www.natureindex.com/ generate?
• http://www.naturechina.com income
• How much cash flow does https://www.natureasia.com/ja-jp have monthly?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Prism.js

Emails and Hosting {✉️}

Mail Servers:

• mxa-002c5801.gslb.pphosted.com
• mxb-002c5801.gslb.pphosted.com

Name Servers:

• pdns1.ultradns.net
• pdns2.ultradns.net
• pdns3.ultradns.org
• pdns4.ultradns.org
• pdns5.ultradns.info
• pdns6.ultradns.co.uk

CDN Services {📦}

• Crossref